Xtant (XTNT) CEO Sean Browne Receives 550,000-Share Award

What Happened Sean Browne, President & CEO and a director of Xtant Medical Holdings (XTNT), was granted 550,000 deferred stock units (DSUs) on 2026-08-15 at $0.00 per share. The DSUs vest in four equal installments of 137,500 shares on Aug 15 of 2027, 2028, 2029 and 2030 and settlement is deferred per the DSU award terms. Separately, 10,605 shares were withheld by the issuer to satisfy tax withholding obligations upon vesting/settlement at $0.31 per share (total ~ $3,288).

Key Details

• Transaction date: 2026-08-15. Grant code: A (award); Tax withholding code: F (shares withheld).
• Grant: 550,000 DSUs at $0.00; vesting schedule: 137,500 shares on each Aug 15 in 2027–2030 (see footnote F1).
• Tax withholding: 10,605 shares withheld at $0.31/share for ~$3,288 (footnote F3).
• Shares issuable/beneficially owned per filing: includes 1,720,123 shares issuable upon vesting/settlement of RSUs/DSUs (footnote F2).
• Filing: Form 4 filed 2026-08-18 for 2026-08-15 transactions; appears to be timely (filed within two business days).

Context DSUs are a non-cash equity award that represent a contingent right to receive one share each upon settlement; vesting is conditioned on continued employment and settlement is deferred per the award agreement. The 10,605-share disposition was for tax withholding (routine), not an open-market sale—these withholdings reduce the number of shares ultimately received upon settlement.